Dermata Therapeutics, Inc. cotiza a 0.86 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatme…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.48 | $-1.52 | $-1.65 | $-1.66 |
| Estimado | $-0.53 | $-1.54 | $-1.59 | $-2.90 |
| Sorpresa | +9.4% | +1.3% | -3.8% | +42.8% |
| Métrica | DRMA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -121.5% | -40.4% | -81.1% |
| ROA | -96.1% | -32.0% | -64.1% |
| Current Ratio | — | 2.84 | — |
| Debt / Equity | — | 0.28 | — |